Long-term oncologic outcomes after fertility-sparing management using oral progestin for young women with endometrial cancer (KGOG 2002)-Reference-Cited by-同舟云学术

Long-term oncologic outcomes after fertility-sparing management using oral progestin for young women with endometrial cancer (KGOG 2002)

Published:2013-03 Issue:4 Volume:49 Page:868-874
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Park Jeong-Yeol,Kim Dae-Yeon,Kim Jong-Hyeok,Kim Yong-Man,Kim Kyu-Rae,Kim Young-Tak,Seong Seok Ju,Kim Tae-Jin,Kim Jae Weon,Kim Seok Mo,Bae Duk-Soo,Nam Joo-Hyun

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference27 articles.

1. Geographic and temporal variations in cancer of the corpus uteri: incidence and mortality in pre- and postmenopausal women in Europe;Bray;Int J Cancer,2005

2. Cancer statistics, 2010;Jemal;CA Cancer J Clin,2010

3. Prediction of cancer incidence and mortality in Korea, 2011;Jung;Cancer Res Treat,2011

4. Current status of gynecologic cancer in Japan;Ushijima;J Gynecol Oncol,2009

5. Current status in the management of uterine corpus cancer in Korea;Jeong;J Gynecol Oncol,2010

Cited by 164 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of extended progestin therapy in atypical endometrial hyperplasia patients without an initial response to progestin: a retrospective study from two tertiary centers in Korea and Taiwan;Journal of Gynecologic Oncology;2025

2. GnRH-a-based fertility-sparing treatment of atypical endometrial hyperplasia (AEH) and early endometrial carcinoma (EC) patients: a multicenter, open-label, randomized designed clinical trial protocol;Trials;2024-09-02

3. Update on the oncologic and obstetric outcomes of medroxyprogesterone acetate treatment for atypical endometrial hyperplasia and endometrial cancer;Journal of Obstetrics and Gynaecology Research;2024-08-02

4. The Analysis of in vitro Fertilization Outcomes after Fertility-Preserving Therapy for Endometrial Hyperplasia or Carcinoma;Gynecologic and Obstetric Investigation;2024-05-22

5. Progesterone Enhances Niraparib Efficacy in Ovarian Cancer by Promoting Palmitoleic-Acid-Mediated Ferroptosis;Research;2024-01